Ivoclar Takes Action to Combat Risks Associated With Counterfeit and Gray Market Products
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Dental practices using Ivoclar materials face compliance and liability risk when gray-market or counterfeit products reach the operatory, potentially triggering regulatory scrutiny or insurance non-payment.
Key points
- Ivoclar is publicly warning dentists about unauthorized channels that bypass FDA and CE quality controls, raising the chance of device recalls or adverse-event reporting.
- Counterfeit or gray-market restorative materials can fail clinical performance standards, leading to re-treatment costs and possible malpractice exposure.
- DSOs and multi-location owners should audit supplier documentation now to ensure lot traceability and avoid future payer claw-backs tied to non-compliant inventory.
- Staff ordering supplies must verify authorized distributors; using unofficial sources may void manufacturer warranties and practice liability coverage.
Who should care
Read the original on Dentistry Today
Full reporting and any paywall content live on dentistrytoday.com. We summarize and score; we do not republish.
Related
- ·Research
National U.S. trial finds silver diamine fluoride ‘effective and safe’ at arresting tooth decay in young children
- ·Regulatory
ADSO sues Colorado Dental Board over practice ownership rule
- ·Regulatory
More than 4 in 5 physicians and dentists say disclosing substance use history could hurt admission chances
- ·Research
Clinical performance of monolithic and veneered zirconia three-unit posterior FDPs: A five-year multicenter randomized controlled trial